The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Therapeutic drug monitoring of antimicrobials
Open accessAbstract
Optimizing the prescription of antimicrobials is required to improve clinical outcome from infections and to reduce the development of antimicrobial resistance. One such method to improve antimicrobial dosing in individual patients is through application of therapeutic drug monitoring (TDM). The aim of this manuscript is to review the place of TDM in the dosing of antimicrobial agents, specifically the importance of pharmacokinetics (PK) and pharmacodynamics (PD) to define the antimicrobial exposures necessary for maximizing killing or inhibition of bacterial growth. In this context, there are robust data for some antimicrobials, including the ratio of a PK parameter (e.g. peak concentration) to the minimal inhibitory concentration of the bacteria associated with maximal antimicrobial effect. Blood sampling of an individual patient can then further define the relevant PK parameter value in that patient and, if necessary, antimicrobial dosing can be adjusted to enable achievement of the target PK/PD ratio. To date, the clinical outcome benefits of a systematic TDM programme for antimicrobials have only been demonstrated for aminoglycosides, although the decreasing susceptibility of bacteria to available antimicrobials and the increasing costs of pharmaceuticals, as well as emerging data on pharmacokinetic variability, suggest that benefits are likely.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kumar, A., Roberts, D., Wood, K. E., Light, B., Parrillo, J. E., Sharma, S., Suppes, R., Feinstein, D., Zanotti, S., Taiberg, L., et al. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000217961.75225.e9 · Cited by 6,109
Craig, W. A. (1998) · Clinical Infectious Diseases · doi:10.1086/516284 · Cited by 2,908
Inadequate Antimicrobial Treatment of Infections
Kollef, M. H., Sherman, G., Ward, S., & Fraser, V. J. (1999) · Chest · doi:10.1378/chest.115.2.462 · Cited by 1,805
Rybak, M., Lomaestro, B., Rotschafer, J. C., Moellering, R., Craig, W., Billeter, M., Dalovisio, J. R., & Levine, D. P. (2009) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp080434 · Cited by 1,795
Talbot, G. H., Bradley, J., Edwards, J. E., Gilbert, D., Scheld, M., & Bartlett, J. G. (2006) · Clinical Infectious Diseases · doi:10.1086/499819 · Cited by 1,104
Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients
Forrest, A., Nix, D. E., Ballow, C. H., Goss, T. F., Birmingham, M. C., & Schentag, J. J. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.5.1073 · Cited by 1,101
Antimicrobial pharmacodynamics: critical interactions of 'bug and drug'
Drusano, G. L. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro862 · Cited by 930
Pharmacokinetic issues for antibiotics in the critically ill patient
Roberts, J. A., & Lipman, J. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181961bff · Cited by 862
Self-citationHidayat, L. K., Hsu, D. I., Quist, R., Shriner, K. A., & Wong-Beringer, A. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.19.2138 · Cited by 860
Rybak, M. J., Lomaestro, B. M., Rotscahfer, J. C., Moellering, R. C., Craig, W. A., Billeter, M., Dalovisio, J. R., & Levine, D. P. (2009) · Clinical Infectious Diseases · doi:10.1086/600877 · Cited by 815
Moise-Broder, P. A., Forrest, A., Birmingham, M. C., & Schentag, J. J. (2004) · Clinical Pharmacokinetics · doi:10.2165/00003088-200443130-00005 · Cited by 757
Correlation of Antimicrobial Pharmacokinetic Parameters with Therapeutic Efficacy in an Animal Model
Vogelman, B., Gudmundsson, S., Leggett, J., Turnidge, J., Ebert, S., & Craig, W. A. (1988) · The Journal of Infectious Diseases · doi:10.1093/infdis/158.4.831 · Cited by 720
Garnacho-Montero, J., Garcia-Garmendia, J. L., Barrero-Almodovar, A., Jimenez-Jimenez, F. J., Perez-Paredes, C., & Ortiz-Leyba, C. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000098031.24329.10 · Cited by 718
Experience with a once-daily aminoglycoside program administered to 2,184 adult patients
Nicolau, D. P., Freeman, C. D., Belliveau, P. P., Nightingale, C. H., Ross, J. W., & Quintiliani, R. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.3.650 · Cited by 641
Effects of Obesity on Pharmacokinetics: Implications for Drug Therapy
Cheymol, G. (2000) · Clinical Pharmacokinetics · doi:10.2165/00003088-200039030-00004 · Cited by 631
Lodise, T. P., Lomaestro, B., Graves, J., & Drusano, G. L. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01602-07 · Cited by 574
Lodise, T. P., Lomaestro, B., & Drusano, G. L. (2007) · Clinical Infectious Diseases · doi:10.1086/510590 · Cited by 527
Antifungal therapeutic drug monitoring: established and emerging indications
Andes, D., Pascual, A., & Marchetti, O. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00705-08 · Cited by 490
McKinnon, P. S., Paladino, J. A., & Schentag, J. J. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.12.009 · Cited by 464
Therapeutic Drug Monitoring in the Treatment of Tuberculosis
Peloquin, C. A. (2002) · Drugs · doi:10.2165/00003495-200262150-00001 · Cited by 446
A suggested approach to once‐daily aminoglycoside dosing.
Begg, E., Barclay, M., & Duffull, S. (1995) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1995.tb05719.x · Cited by 420
Rybak, M. J., Lomaestro, B. M., Rotschafer, J. C., Moellering, R. C., Craig, W. A., Billeter, M., Dalovisio, J. R., & Levine, D. P. (2009) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.29.11.1275 · Cited by 403
Wysocki, M., Delatour, F., Faurisson, F., Rauss, A., Pean, Y., Misset, B., Thomas, F., Timsit, J.-F., Similowski, T., Mentec, H., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.9.2460-2467.2001 · Cited by 385
Augmented Renal Clearance: Implications for Antibacterial Dosing in the Critically Ill
Udy, A. A., Roberts, J. A., Boots, R. J., Paterson, D. L., & Lipman, J. (2010) · Clinical Pharmacokinetics · doi:10.2165/11318140-000000000-00000 · Cited by 377
Self-citationInsufficient β-lactam concentrations in the early phase of severe sepsis and septic shock
Taccone, F. S., Laterre, P.-F., Dugernier, T., Spapen, H., Delattre, I., Wittebole, X., De Backer, D., Layeux, B., Wallemacq, P., Vincent, J.-L., et al. (2010) · Critical Care · doi:10.1186/cc9091 · Cited by 369
Pharmacokinetics of vancomycin in patients with various degrees of renal function
Matzke, G. R., McGory, R. W., Halstenson, C. E., & Keane, W. F. (1984) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.25.4.433 · Cited by 362
Antibiotic resistance—What’s dosing got to do with it?
Roberts, J. A., Kruger, P., Paterson, D. L., & Lipman, J. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e318180fe62 · Cited by 339
Self-citationTherapeutic drug monitoring of β-lactams in critically ill patients: proof of concept
Roberts, J. A., Ulldemolins, M., Roberts, M. S., McWhinney, B., Ungerer, J., Paterson, D. L., & Lipman, J. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.06.008 · Cited by 334
Self-citationKinetics of antimicrobial activity
Vogelman, B., & Craig, W. A. (1986) · The Journal of Pediatrics · doi:10.1016/s0022-3476(86)80754-5 · Cited by 315
Rayner, C. R., Forrest, A., Meagher, A. K., Birmingham, M. C., & Schentag, J. J. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342150-00007 · Cited by 306
Clinical Pharmacodynamics of Meropenem in Patients with Lower Respiratory Tract Infections
Li, C., Du, X., Kuti, J. L., & Nicolau, D. P. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00294-06 · Cited by 289
Roberts, J. A., & Lipman, J. (2006) · Clinical Pharmacokinetics · doi:10.2165/00003088-200645080-00001 · Cited by 283
Self-citationMouton, J. W., & den Hollander, J. G. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.5.931 · Cited by 275
Clinical Pharmacokinetics of Teicoplanin
Rowland, M. (1990) · Clinical Pharmacokinetics · doi:10.2165/00003088-199018030-00002 · Cited by 263
van Lent-Evers, N. A. E. M., Mathôt, R. A. A., Geus, W. P., van Hout, B. A., & Vinks, A. A. T. M. M. (1999) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199902000-00010 · Cited by 244
Roberts, J. A., Taccone, F. S., Udy, A. A., Vincent, J.-L., Jacobs, F., & Lipman, J. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01708-10 · Cited by 226
Self-citationJeffres, M. N., Isakow, W., Doherty, J. A., McKinnon, P. S., Ritchie, D. J., Micek, S. T., & Kollef, M. H. (2006) · Chest · doi:10.1378/chest.130.4.947 · Cited by 219
Analysis of 12 beta-lactam antibiotics in human plasma by HPLC with ultraviolet detection
McWhinney, B. C., Wallis, S. C., Hillister, T., Roberts, J. A., Lipman, J., & Ungerer, J. P. J. (2010) · Journal of Chromatography B · doi:10.1016/j.jchromb.2010.05.027 · Cited by 209
Self-citationThe therapeutic monitoring of antimicrobial agents
Begg, E. J., Barclay, M. L., & Kirkpatrick, C. J. M. (1999) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1999.00850.x · Cited by 200
Therapeutic Drug Monitoring of Linezolid: a Retrospective Monocentric Analysis
Pea, F., Furlanut, M., Cojutti, P., Cristini, F., Zamparini, E., Franceschi, L., & Viale, P. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00177-10 · Cited by 198
Pharmacokinetics and Pharmacodynamics of Meropenem in Febrile Neutropenic Patients with Bacteremia
Ariano, R. E., Nyhlén, A., Donnelly, J. P., Sitar, D. S., Harding, G. K., & Zelenitsky, S. A. (2005) · Annals of Pharmacotherapy · doi:10.1345/aph.1e271 · Cited by 185
Pharmacokinetics of vancomycin
Moellering, R. C. (1984) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/14.suppl_d.43 · Cited by 178
Therapeutic Drug Monitoring of Antifungals: Pharmacokinetic and Pharmacodynamic Considerations
Smith, J., & Andes, D. (2008) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e318167d0e0 · Cited by 156
Vogelman, B., & Craig, W. A. (1985) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/15.suppl_a.37 · Cited by 153
Aminoglycoside Volume of Distribution and Illness Severity in Critically Ill Septic Patients
Marik, P. E. (1993) · Anaesthesia and Intensive Care · doi:10.1177/0310057x9302100206 · Cited by 145
Suboptimal Aminoglycoside Dosing in Critically Ill Patients
Rea, R. S., Capitano, B., Bies, R. R., Bigos, K. L., Smith, R. B., & Lee, H. (2008) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e31818b6b2f · Cited by 145
Pea, F. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg147 · Cited by 144
Mouton, J. W., Vinks, A. A. T. M. M., & Punt, N. C. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.4.733 · Cited by 142
Pneumonia caused by oxacillin-resistant Staphylococcus aureus treated with glycopeptides*
Rello, J., Solé‐Violán, J., Borges-Sa, M., Garnacho‐Montero, J., Muñoz, E., Sirgo, G., Olona, M., & Dı́az, E. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000178180.61305.1d · Cited by 141
Pea, F., Furlanut, M., Negri, C., Pavan, F., Crapis, M., Cristini, F., & Viale, P. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01149-08 · Cited by 118
Matthews, I., Kirkpatrick, C. M. J., & Holford, N. H. G. (2004) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2004.02114.x · Cited by 110
Target concentration intervention: beyond Y2K
Holford, N. H. G. (1999) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1999.00971.x · Cited by 109
Continuous infusion of beta-lactams
Mouton, J. W., & Vinks, A. A. T. M. M. (2007) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e3282e2a98f · Cited by 103
Li, A. M. M. Y., Gomersall, C. D., Choi, G. Y. S., Tian, Q., Joynt, G. M., & Lipman, J. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp302 · Cited by 93
Optimization of Aminoglycoside Therapy
Drusano, G. L., & Louie, A. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01314-10 · Cited by 92
Can PK/PD be used in everyday clinical practice
Scaglione, F. (2002) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(02)00020-1 · Cited by 89
Pharmacological Issues of Linezolid: An Updated Critical Review
Paolo, A. D., Malacarne, P., Guidotti, E., Danesi, R., & Tacca, M. D. (2010) · Clinical Pharmacokinetics · doi:10.2165/11319960-000000000-00000 · Cited by 85
Cefepime Versus Cefpirome: The Importance of Creatinine Clearance
Lipman, J., Wallis, S. C., & Boots, R. J. (2003) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000077077.54084.b0 · Cited by 85
Determination of ciprofloxacin in plasma and urine by HPLC with ultraviolet detection
Kamberi, M., Tsutsumi, K., Kotegawa, T., Nakamura, K., & Nakano, S. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.6.1251 · Cited by 80
Brink, A. J., Richards, G. A., Cummins, R. R., & Lambson, J. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.05.012 · Cited by 80
Lodise, T. P., Miller, C. D., Graves, J. P., Evans, A. M., Graffunder, E. M., Helmecke, M. R., & Stellrecht, K. A. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn329 · Cited by 72
Roosendaal, R., Bakker‐Woudenberg, I. A. J. M., Raffe, M. V. D. B.-V., Berg, J., & MICHEL, M. F. (1989) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01963774 · Cited by 70
Sun, H., He, P., Lv, Y., & Liang, S. (2007) · Journal of Chromatography B · doi:10.1016/j.jchromb.2007.01.016 · Cited by 68
Using PK/PD to Optimize Antibiotic Dosing for Critically Ill Patients
Roberts, J. A. (2011) · Current Pharmaceutical Biotechnology · doi:10.2174/138920111798808329 · Cited by 67
Self-citationTherapeutic drug monitoring of β-lactams for critically ill patients: unwarranted or essential?
Roberts, J. A., Hope, W. W., & Lipman, J. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.01.022 · Cited by 66
Self-citationDaily serum piperacillin monitoring is advisable in critically ill patients
Blondiaux, N., Wallet, F., Favory, R., Onimus, T., Nseir, S., Courcol, R., Durocher, A., & Roussel‐Delvallez, M. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.01.018 · Cited by 64
Gous, A. G. S., Lipman, J., Scribante, J., Tshukutsoane, S., Hon, H., Pinder, M., Mathivha, R. L., Verhoef, L., & Staß, H. (2005) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2005.04.005 · Cited by 49
Norris, R. L. G., Martin, J. H., Thompson, E., Ray, J. E., Fullinfaw, R. O., Joyce, D. A., Barras, M. A., Jones, G. R. D., & Morris, R. G. (2010) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e3181ea3e8a · Cited by 39
Self-citationImpact of dosage schedule of antibiotics on the treatment of serious infections
Bakker‐Woudenberg, I. A. J. M., & Roosendaal, R. (1990) · Intensive Care Medicine · doi:10.1007/bf01709706 · Cited by 31
Stahlmann, S., & Kovar, K. (1998) · Journal of Chromatography A · doi:10.1016/s0021-9673(98)00334-3 · Cited by 28
Validation of the Hartford Nomogram in Trauma Surgery Patients
Finnell, D. L., Davis, G. A., Cropp, C., & Ensom, M. H. (1998) · The Annals of Pharmacotherapy · doi:10.1345/aph.17243 · Cited by 28
Vancomycin Assay Performance in Patients with End‐Stage Renal Disease Receiving Hemodialysis
Kingery, J. R., Sowinski, K. M., Kraus, M. A., Klaunig, J. E., & Mueller, B. A. (2000) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.20.7.653.35177 · Cited by 6
Appropriate Pharmacokinetic Index for Outcome in Staphylococcus aureus Pneumonia
Potoski, B. A., & Paterson, D. L. (2007) · CHEST Journal · doi:10.1378/chest.06-2839 · Cited by 6
Self-citation
Cited by
Tetracycline antibiotics in the environment: a review
Daghrir, R., & Drogui, P. (2013) · Environmental Chemistry Letters · doi:10.1007/s10311-013-0404-8 · Cited by 1,595
Roberts, J. A., Abdul-Aziz, M. H., Lipman, J., Mouton, J. W., Vinks, A. A., Felton, T. W., Hope, W. W., Farkas, A., Neely, M. N., Schentag, J. J., et al. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70036-2 · Cited by 1,046
Self-citationAntimicrobial Stewardship: Fighting Antimicrobial Resistance and Protecting Global Public Health
Majumder, M. A. A., Rahman, S., Cohall, D., Bharatha, A., Singh, K., Haque, M., & Gittens-St Hilaire, M. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s290835 · Cited by 633
Opportunities and challenges in the diagnostic utility of dermal interstitial fluid
Friedel, M., Thompson, I. A. P., Kasting, G., Polsky, R., Cunningham, D., Soh, H. T., & Heikenfeld, J. (2023) · Nature Biomedical Engineering · doi:10.1038/s41551-022-00998-9 · Cited by 360
Nation, R. L., Li, J., Cars, O., Couet, W., Dudley, M. N., Kaye, K. S., Mouton, J. W., Paterson, D. L., Tam, V. H., Theuretzbacher, U., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70850-3 · Cited by 354
Self-citation
Metadata
- Authors
- Roberts, J. A., Norris, R., Paterson, D. L., & Martin, J. H.
- Venue
- British Journal of Clinical Pharmacology
- Publisher
- Wiley
- Published
- 2011-12-08
- Volume
- 73
- Issue
- 1
- Pages
- 27-36
- ISSN
- 0306-5251 (ISSN-L)
- 1365-2125
- OpenAlex
- W1561900493
- Cited by
- 316
- References
- 73
- FWCI
- 8.97
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.